Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Cancer Sci. 2013 Jan;104(1):130-4. doi: 10.1111/cas.12048. Epub 2012 Dec 4.
To investigate the possible influences of various factors on tumor response to radiation, regression speeds and long-term local control rates of primary adenocarcinoma and squamous cell carcinoma of the lung after stereotactic body radiotherapy were evaluated. Ninety-one patients (65 men and 26 women) with a median age of 76 years were serially examined using computed tomography at 2, 4 and 6 months after treatment. Tumor histology was adenocarcinoma in 62 patients and squamous cell carcinoma in 29 patients. The prescribed dose was 48 Gy in four fractions given twice a week for T1 tumors (≤ 3 cm) and 52 Gy in four fractions given twice a week for T2 tumors (3-5 cm). Tumor shrinkage speed and 3-year local control rates were similar between T1 and T2 tumors and between patients with normal pulmonary function and those with impaired function. Squamous cell carcinomas shrank faster than adenocarcinomas at 2 and 4 months after radiation, but mean relative tumor size at 6 months and local control rates at 3 years did not differ significantly between the two histologies. Tumors in patients with a higher hemoglobin level tended to shrink faster but the control rates were not different. It is concluded that, although squamous cell carcinoma shrinks faster than adenocarcinoma, the two types of lung cancer are of similar radiosensitivity in terms of long-term control rates. Radiosensitivity should not be evaluated by early tumor response.
为了研究各种因素对肿瘤放疗反应的可能影响,我们评估了立体定向体部放疗后原发性肺腺癌和鳞癌的回归速度和长期局部控制率。91 例患者(65 例男性,26 例女性),中位年龄为 76 岁,在治疗后 2、4 和 6 个月分别通过 CT 进行连续检查。肿瘤组织学为腺癌 62 例,鳞癌 29 例。T1 肿瘤(≤3cm)处方剂量为 48Gy 分 4 次,每周 2 次;T2 肿瘤(3-5cm)处方剂量为 52Gy 分 4 次,每周 2 次。T1 和 T2 肿瘤之间、肺功能正常和受损患者之间,肿瘤退缩速度和 3 年局部控制率相似。鳞癌在放疗后 2 个月和 4 个月时比腺癌退缩更快,但 6 个月时平均相对肿瘤大小和 3 年局部控制率在两种组织学类型之间无显著差异。血红蛋白水平较高的患者肿瘤往往退缩更快,但控制率无差异。结论:虽然鳞癌比腺癌退缩更快,但就长期控制率而言,两种肺癌的放射敏感性相似。不应通过早期肿瘤反应来评估放射敏感性。